Daniel R. Passeri
2018 - Cue Biopharma
In 2018, Daniel R. Passeri earned a total compensation of $833.9K as Chief Executive Officer at Cue Biopharma.
Compensation breakdown
| Bonus | $103,500 |
|---|---|
| Option Awards | $381,163 |
| Salary | $345,000 |
| Other | $4,195 |
| Total | $833,858 |
Passeri received $381.2K in option awards, accounting for 46% of the total pay in 2018.
Passeri also received $103.5K in bonus, $345K in salary and $4.2K in other compensation.
Rankings
In 2018, Daniel R. Passeri's compensation ranked 10,011th out of 14,244 executives tracked by ExecPay. In other words, Passeri earned more than 29.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,011 out of 14,244 | 30th |
Division Manufacturing | 4,040 out of 5,762 | 30th |
Major group Chemicals And Allied Products | 1,519 out of 2,125 | 29th |
Industry group Drugs | 1,282 out of 1,814 | 29th |
Industry Pharmaceutical Preparations | 985 out of 1,388 | 29th |
Source: SEC filing on May 29, 2020.
Passeri's colleagues
We found two more compensation records of executives who worked with Daniel R. Passeri at Cue Biopharma in 2018.